Fundamental Analysis
63 / 100ARubric: Manufacturing
| Quarterly results | Relative Valuation | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Criterion | Latest Q EPS growth (YoY) | Avg EPS growth, last 3 (YoY) | Quarters with EPS growth | Revenue growth (YoY) | Gross margin change (pp, YoY) | Net margin change (pp, YoY) | Return on Equity (TTM) | Financial health (Debt/Equity) | Valuation (P/E vs 5-yr median) | Revenue (bn) | Rev YoY | NPAT (bn) | NPAT YoY | P/E | 5-Year Median P/E | P/E vs. 5-Year Median |
| Value | +117.7% | +44.0% | 2 / 3 | +12.9% | +0.08 pp | +7.28 pp | +10.0% | 0.33 | 9.25 | 110 | +12,9% | 14,7 | +148,3% | 9.25 | 7.35 | +25,8% |
| Pts | 12 | 8 | 8 | 4 | 8 | 12 | 0 | 12 | 4 | |||||||
Valuation annotation:Price: 11.500 (close price on 2026-09-15)EPS (TTM): 1.244
Financial charts
1.Revenue & growth
VND bn110Q2/26
1.Revenue & growth
VND bn110Q2/26
2.Profit & growth
VND bn8,95Q2/26
3.Profit mix (Penman)
VND bn50,5Q2/26
4.Margins & cost structure
%18.5%Q2/26
5.Returns & cash cycle
% · days4.8%Q2/26
6.Earnings quality & cash
VND bn
7.Asset structure
VND bn765Q2/26
8.Funding & debt health
VND bn · times765Q2/26
9.Revenue backlog
VND bn78,0Q2/26
10.Valuation
times · %9,2×Q2/26
11.EPS growth & dilution warning (CANSLIM)
VND per share; growth in %326Q2/26
Adjusted EPS growth, latest quarter
118%
Average adjusted EPS growth, 3 quarters
44.0%
Quarters at 25%+ growth
2/3
Share dilution rate, 1 year
0.0%
Source: vnstockData through Q2/26